Quest Diagnostics DGX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Quest Diagnostics's investing cash flow?
- Quest Diagnostics (DGX) reported investing cash flow of -$152M in Q1 2026.
- How has Quest Diagnostics's investing cash flow changed year-over-year?
- Quest Diagnostics's investing cash flow decreased by 32.2% year-over-year, from -$115M to -$152M.
- What is the long-term trend for Quest Diagnostics's investing cash flow?
- Over 3 years (2022 to 2025), Quest Diagnostics's investing cash flow has grown at a 5.1% compound annual growth rate (CAGR), from -$543M to -$631M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.